COMMUNIQUÉS West-GlobeNewswire

Alvotech announces successful closure of FDA inspection of manufacturing facility
29/07/2026
REYKJAVIK, Iceland, July 29, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for [...]
Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France
29/07/2026
July 28, 2026 Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products [...]
Jushi Holdings Provides Update on Plan of Arrangement
29/07/2026
BOCA RATON, Fla., July 29, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“ Jushi ” or the “ Company ”) ( CSE: JUSH ) ( OTCQX: JUSHF ) , a vertically integrated, multi-state cannabis operator, announces that, further to [...]
Walmart Canada, ses associés et ses clients recueillent 7,2 millions de dollars pour soutenir les hôpitaux pour enfants partout au Canada
29/07/2026
MISSISSAUGA, Ontario, 29 juill. 2026 (GLOBE NEWSWIRE) -- Walmart Canada, ses associés et ses clients se sont de nouveau mobilisés ce printemps et ont recueilli 7,2 millions de dollars pour soutenir les fondations d’ [...]
Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation
29/07/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been granted De Novo classification by the U.S. Food & Drug Administration (FDA) for its TESSA Spatial Surgery System. [...]
Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons
29/07/2026
Exclusive Partnership Offers The Maidstone Guests Access and Savings on Flyte's Private Travel Services Collaboration Marks the Beginning of a Long-Term Relationship Connecting Luxury Hospitality with Modern Private [...]
Angelman Syndrome Foundation and Citizen Health Partner to Put Advanced AI to Work for Every Angelman Family
29/07/2026
Citizen Health's AI advocate for rare disease families debuts for the Angelman community at the 2026 ASF Family Conference SAN FRANCISCO and DENVER, July 29, 2026 (GLOBE NEWSWIRE) -- The Angelman Syndrome Foundation ( [...]
BPC-157 Introduced by Kylo Peptides for Laboratory Research Purposes
29/07/2026
Sheridan, Wyoming, July 29, 2026 (GLOBE NEWSWIRE) -- Kylo Peptides, a United States research peptide supplier, today announced the addition of BPC-157 to its catalog of research compounds. The synthetic peptide is [...]
Cynet Releases 1H 2026 CyOps ECHO Report: Abused Identities, Gateways, and Trust Take the Place of Exploited Code
29/07/2026
Incident responders document how adversaries are gaining initial footholds through stolen or socially-engineered identities rather than CVE exploitation BOSTON, July 29, 2026 (GLOBE NEWSWIRE) -- Cynet , the only unified [...]
Walmart Canada, Associates and Customers Raise $7.2 Million to Support Children’s Hospitals Across Canada
29/07/2026
MISSISSAUGA, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- Walmart Canada, associates and customers came together once again this spring, raising $7.2 million to support children’s hospital foundations across the country. [...]
Alvotech announces successful closure of FDA inspection of manufacturing facility
29/07/2026
REYKJAVIK, ICELAND (July 29, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
29/07/2026
WEST PALM BEACH, FL, July 29, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc.’s (OTC: FOXOD/FOXO) ( “FOXO”) subsidiary, Vector BioSource, Inc. (“Vector”) today announced that it has entered into a definitive agreement [...]
TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages
29/07/2026
-Carbonium Merger Remains on Track -European Regulatory Expansion and Partnership Growth -Advancement of Biosafety Cabinet Standards -Defense Sector Growth FREDERICK, Md., July 29, 2026 (GLOBE NEWSWIRE) -- TOMI [...]
TimelyCare Sets New Standard for Student Safety with URAC Artificial Intelligence in Healthcare Accreditation
29/07/2026
Independent review validates the governance, safeguards and accountability supporting TimelyCare’s responsible use of AI Fort Worth, TX, July 29, 2026 (GLOBE NEWSWIRE) -- Prioritizing student safety and well-being in [...]
CorMedix Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 13, 2026
29/07/2026
PARSIPPANY, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD) today announced that it will report its financial results for the second quarter ended June 30, 2026, before the market opens on [...]
LB Pharmaceuticals Announces $150 Million Private Placement
29/07/2026
NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]
PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
29/07/2026
Acquisition brings into Processa’s pipeline Vidya’s lead asset, VT-7208, a next-generation, CNS-penetrant, once-daily, oral potentially best-in-class Bruton’s tyrosine kinase inhibitor (BTKi) designed to overcome the [...]
XORTX Appoints New Director
29/07/2026
CALGARY, Alberta, July 29, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing [...]
BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026
29/07/2026
BURLINGTON, Mass. and JERUSALEM, July 29, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today [...]

Pages